171 related articles for article (PubMed ID: 488011)
1. Comparison between the action of estradiol and that of the antiestrogen U 11-100 A on the induction in the rat uterus of a specific protein (the induced protein).
Mairesse N; Galand P
Endocrinology; 1979 Nov; 105(5):1248-53. PubMed ID: 488011
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
Katzenellenbogen BS; Ferguson ER
Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
Ferguson ER; Katzenellenbogen BS
Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
[TBL] [Abstract][Full Text] [Related]
4. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
Attardi B; Palumbo LA
Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
[TBL] [Abstract][Full Text] [Related]
5. Nafoxidine-responsive uterine protein: further characterization and distinction from the "estrogen-induced" protein (IP).
Mairesse N; Reiss N; Galand P; Kaye AM
Mol Cell Endocrinol; 1981 Oct; 24(1):53-63. PubMed ID: 6173271
[TBL] [Abstract][Full Text] [Related]
6. Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action.
Katzenellenbogen BS; Ferguson ER; Lan NC
Endocrinology; 1977 May; 100(5):1252-9. PubMed ID: 849722
[TBL] [Abstract][Full Text] [Related]
7. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
Gardner RM; Kirkland JL; Stancel GM
Endocrinology; 1978 Nov; 103(5):1583-9. PubMed ID: 748005
[TBL] [Abstract][Full Text] [Related]
8. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
Ruh TS; Baudendistel LJ
Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogens: effects of tamoxifen, nafoxidine, and CI-628 on sexual behavior, cytoplasmic receptors, and nuclear binding of estrogen.
Etgen AM
Horm Behav; 1979 Oct; 13(2):97-112. PubMed ID: 399606
[No Abstract] [Full Text] [Related]
10. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.
Eckert RL; Mullick A; Rorke EA; Katzenellenbogen BS
Endocrinology; 1984 Feb; 114(2):629-37. PubMed ID: 6690295
[TBL] [Abstract][Full Text] [Related]
11. Different stability during incubation in vitro of the induced-protein (IP) response elicited in the rat uterus by treatment in vivo with oestradiol-17 beta or Nafoxidine [proceedings].
Mairesse N; Galand P
Arch Int Physiol Biochim; 1977 Dec; 85(5):1003-4. PubMed ID: 79342
[No Abstract] [Full Text] [Related]
12. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of estrogen and antiestrogen on plasma renin substrate levels and hepatic estrogen receptors in the rat.
Kneifel MA; Katzenellenbogen BS
Endocrinology; 1981 Feb; 108(2):545-52. PubMed ID: 7004858
[No Abstract] [Full Text] [Related]
14. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.
Gulino A; Pasqualini JR
Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065
[TBL] [Abstract][Full Text] [Related]
15. The capacity of the antiestrogen CI-628 to activate the estrogen receptor in vitro.
De Boer W; Notides AC; Katzenellenbogen BS; Hayes JR; Katzenellenbogen JA
Endocrinology; 1981 Jan; 108(1):206-12. PubMed ID: 7007019
[No Abstract] [Full Text] [Related]
16. Antiestrogen inhibits the induction of progestin receptors by estradiol in the hypothalamus-preoptic area and pituitary.
Roy EJ; MacLusky NJ; McEwen BS
Endocrinology; 1979 May; 104(5):1333-6. PubMed ID: 220031
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the estradiol-induced luteinizing hormone surge by progesterone or antiestrogens: effects on pituitary gonadotropin-releasing hormone receptors.
Attardi B; Happe HK
Endocrinology; 1986 Jul; 119(1):274-83. PubMed ID: 3013589
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division.
Mukku VR; Kirkland JL; Hardy M; Stancel GM
Endocrinology; 1981 Oct; 109(4):1005-10. PubMed ID: 7285857
[TBL] [Abstract][Full Text] [Related]
19. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus.
van Doorn LG; Poortman J; Thijssen JH; Schwarz F
Endocrinology; 1981 Apr; 108(4):1587-93. PubMed ID: 7472285
[TBL] [Abstract][Full Text] [Related]
20. Differential blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
Galand P; Mairesse N; Roorijck J; Flandroy L
J Steroid Biochem; 1983 Sep; 19(3):1259-63. PubMed ID: 6194375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
